MetaADEDB 2.0 @ LMMD
Loteprednol Etabonate
(YPZVAYHNBBHPTO-MXRBDKCISA-N)
Structure
SMILES
ClCOC(=O)[C@@]1(O)CC[C@@H]2[C@]1(C)C[C@H](O)[C@H]1[C@H]2CCC2=CC(=O)C=C[C@]12C
Type(s)
Approved; Experimental
ATC code(s)
S01BA14
Molecular Formula:
C21H27ClO5
Molecular Weight:
394.889
Log P:
2.7357
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
2
TPSA:
83.83
CAS Number(s):
129260-79-3
Synonym(s)
1.
Loteprednol Etabonate
2.
Alrex
3.
CEHOAC
4.
Chloromethyl 17-ethoxycarbonyloxy-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate
5.
Lotemax
6.
Loteprednol
7.
17-ethoxycarbonyloxy-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate, Chloromethyl
8.
Chloromethyl 17 ethoxycarbonyloxy 11 hydroxy 3 oxoandrosta 1,4 diene 17 carboxylate
9.
Etabonate, Loteprednol
External Link(s)
MeSHD000069559
PubChem Compound9865442
ChEBI50848
DrugBankDB00873
KEGGdr:D08147
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Abnormal visionSIDER
2Anterior chamber inflammationSIDER
3ConjunctivitisSIDER
4Corneal thinningSIDER
5DiscomfortSIDER
6Eye InfectionSIDER
7Eye irritationSIDER
8Eye painSIDER
9HeadacheSIDER
10KeratitisSIDER
11KeratoconjunctivitisSIDER
12Nerve injurySIDER
13PainSIDER
14PharyngitisSIDER
15PhotophobiaSIDER
16Posterior subcapsular cataractSIDER
17PruritusSIDER
18RhinitisSIDER
19UveitisSIDER
20Visual ImpairmentSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.